Robert Burns Archives

H.C. Wainwright Thinks Nucana’s Stock is Going to Recover

In a report released today, Robert Burns from H.C. Wainwright reiterated a Buy rating on Nucana (NCNA – Research Report),

In a report released today, Robert Burns from H.C. Wainwright reiterated a Buy rating on Autolus Therapeutics (AUTL – Research

In a report released today, Robert Burns from H.C. Wainwright reiterated a Buy rating on Neoleukin Therapeutics (NLTX – Research

In a report released today, Robert Burns from H.C. Wainwright reiterated a Buy rating on Black Diamond Therapeutics (BDTX –

In a report released today, Robert Burns from H.C. Wainwright reiterated a Buy rating on CytomX Therapeutics (CTMX – Research

Zymeworks (ZYME – Research Report) received a Buy rating and a $57.00 price target from H.C. Wainwright analyst Robert Burns

In a report released today, Robert Burns from H.C. Wainwright reiterated a Hold rating on BioNTech SE (BNTX – Research

1 2 3 … 8 »